ei ole lubatud
ei ole lubatud
Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).
Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)
PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )
Seda e-raamatut ei saa lugeda Amazon Kindle's.
Inflammation, immunity and vaccine development for the gastric pathogen Helicobacter pylori.- Impact of Helicobacter pylori Virulence Factors on the Host immune Response and Gastric Pathology.- Genetic polymorphisms in inflammatory and other regulators in gastric cancer: risks and clinical consequences.- MALT lymphoma as a model of chronic inflammation-induced gastric tumor development.- Crosstalk between DNA damage and inflammation in the multiple steps of gastric carcinogenesis.- Importance of toll-like receptors in pro-inflammatory and anti-inflammatory responses by Helicobacter pylori infection.- Role of NOD1 and ALPK1/TIFA signalling in innate immunity against Helicobacter pylori infection.- Carbohydrate-dependent and antimicrobial peptide defense mechanisms against Helicobacter pylori infections.- The sweeping role of cholesterol depletion in the persistence of Helicobacter pylori infections.- Helicobacter pylori deregulates T and B cell signaling to trigger immune evasion.- Mechanisms of inflammasome signaling, microRNA induction and resolution of inflammation by Helicobacter pylori.- Impact of the gastrointestinal microbiome in health and disease: co-evolution with the host immune system.- Resolution of gastric cancer-promoting inflammation: a novel strategy for anti-cancer therapy.